Processa Pharmaceuticals (PCSA) Asset Writedowns and Impairment (2015)
Processa Pharmaceuticals' (PCSA) quarterly Asset Writedowns and Impairment came in at $1.5 million in Q4 2015, up 2635.36% on a QoQ basis from $54558.0 in Q3 2015.
Processa Pharmaceuticals (PCSA) Asset Writedowns and Impairment (2015) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 1 years of Asset Writedowns and Impairment data on file, last reported at $1.5 million in Q4 2015.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $1.5 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $3.1 million (changed N/A YoY) and the FY2022 annual result came in at $7.3 million, changed N/A from the prior year.
- Asset Writedowns and Impairment improved to $1.5 million in Q4 2015, from $54558.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.5 million in Q2 2015 to a low of $25500.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Processa Pharmaceuticals | 5.69 Mn | 5.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1.49 Mn |
| Dec 31, 2015 | 1.49 Mn |
| Sep 30, 2015 | 54,558.00 |
| Sep 30, 2015 | 54,558.00 |
| Jun 30, 2015 | 1.52 Mn |
| Jun 30, 2015 | 1.52 Mn |
| Mar 31, 2015 | 25,500.00 |
| Mar 31, 2015 | 25,500.00 |